Literature DB >> 6263071

Management of recurrent ventricular tachyarrhythmias associated with Q-T prolongation.

M M Khan, K R Logan, J M McComb, A A Adgey.   

Abstract

Eleven patients with acquired prolongation of the Q-Tc interval and recurrent ventricular tachyarrhythmias were studied. Five patients required 5 to 44 direct current shocks to correct prolonged ventricular tachyarrhythmias, and five were given at least two antiarrhythmic agents in an attempt to control the arrhythmias. In 4 of the 11 patients, when thioridazine, diuretic drugs and antiarrhythmic agents were withdrawn and hypokalemia or hypocalcemia corrected, ventricular tachyarrhythmias did not recur. The Q-Tc interval normalized in 2 to 3 days. Ventricular tachyarrhythmias were recurrent in the remaining seven patients, despite withdrawal of the drugs that caused the Q-Tc prolongation, attempted correction of hypokalemia when present and the administration of antiarrhythmic agents to four of the seven. All antiarrhythmic agents were then withdrawn in this group. Immediately on the establishment of overdrive ventricular or atrioventricular sequential pacing in these patients, ventricular tachyarrhythmias were abolished. No breakthrough ventricular tachyarrhythmias occurred during temporary pacing. Temporary pacing was required for an average of 10 days and the Q-Tc interval normalized an average of 5 days from the onset of pacing. Three patients required a permanent pacemaker, one because of chronic complete heart block, one because of the sick sinus syndrome, and one because of frequent ventricular ectopic complexes complicating ischemic heart disease. All 11 patients survived their period of hospitalization.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263071     DOI: 10.1016/0002-9149(81)90263-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Torsade de pointes: chaos, sixteen years on?

Authors:  J G Cleland; D M Krikler
Journal:  Br Heart J       Date:  1992-01

2.  Sotalol, hypokalaemia, syncope, and torsade de pointes.

Authors:  J K McKibbin; W A Pocock; J B Barlow; R N Millar; I W Obel
Journal:  Br Heart J       Date:  1984-02

Review 3.  Class III antiarrhythmics in overdose. Presenting features and management principles.

Authors:  E W Leatham; D W Holt; W J McKenna
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

4.  H2-receptor antagonism is not pro-arrhythmic in a chronic canine model.

Authors:  A C Uprichard; D W Harron
Journal:  Basic Res Cardiol       Date:  1990 Sep-Oct       Impact factor: 17.165

Review 5.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

6.  Torsades de pointes, a common arrhythmia, induced by medication.

Authors:  P T Ko; S Gulamhusein; W J Kostuk; G J Klein
Journal:  Can Med Assoc J       Date:  1982-09-01       Impact factor: 8.262

7.  Aggravation of ventricular arrhythmia. A drug-induced complication.

Authors:  P J Podrid
Journal:  Drugs       Date:  1985       Impact factor: 9.546

8.  Ventricular arrhythmias complicating weight reduction therapy in a patient with a prolonged QT interval.

Authors:  J C O'Keefe; G S Butrous; D S Dymond; P Littlejohns; N Peters; S O Banim
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

Review 9.  Torsade de pointes. Mechanisms and management.

Authors:  C Napolitano; S G Priori; P J Schwartz
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

10.  Recurrent torsade de pointes type ventricular tachycardia in intracranial hemorrhage.

Authors:  S Sen; T Stober; L Burger; T Anstätt; G Rettig
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.